Tag: press release 3

Aer Therapeutics Closes $36 Million Series A to Advance Development of AER-01, an Innovative Mucolytic for the Treatment of Lung Diseases

Supported by premier life science industry investors Canaan, OrbiMed, and Hatteras Venture

Read More
Scroll to Top